Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-06-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.0400187101PMID 15197275PMCID PMC438952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• X-ray snapshots of the maturation of an antibody response to a protein antigen

  2003cited by this paper
• New technologies in therapeutic antibody development.

  2003cited by this paper
• Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis.

  2003cited by this paper
• Engineered antibodies

  2003cited by this paper
• Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library

  2003cited by this paper
• Genetic Analysis of the Twin Arginine Translocator Secretion Pathway in Bacteria*

  2002cited by this paper
• Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

  2002cited by this paper
• High-throughput antibody isolation.

  2001cited by this paper
• Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS)

  2001cited by this paper
• Protein design and phage display.

  2001cited by this paper
• YidC mediates membrane protein insertion in bacteria

  2000cited by this paper
• The single cell as a microplate well

  2000cited by this paper
• A new ABC transporter mediating the detachment of lipid-modified proteins from membranes

  2000cited by this paper
• Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies.

  2000cited by this paper
• Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.

  2000cited by this paper
• Yeast surface display for directed evolution of protein expression, affinity, and stability.

  2000cited by this paper
• Function-based isolation of novel enzymes from a large library

  2000cited by this paper
• Analysis of large libraries of protein mutants using flow cytometry.

  2000cited by this paper
• Phage-display technology--finding a needle in a vast molecular haystack.

  1999cited by this paper
• Escherichia coli skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments.

  1999cited by this paper
• In vitro scanning saturation mutagenesis of all the specificity determining residues in an antibody binding site.

  1999cited by this paper
• Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface.

  1999cited by this paper
• Testing the ‘+2 rule’ for lipoprotein sorting in the Escherichia coli cell envelope with a new genetic selection

  1999cited by this paper
• The ClpXP and ClpAP proteases degrade proteins with carboxy-terminal peptide tails added by the SsrA-tagging system.

  1998cited by this paper
• In vitro selection and evolution of functional proteins by using ribosome display.

  1997cited by this paper
• Membrane-protein engineering.

  1997cited by this paper
• Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system.

  1997cited by this paper
• Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.

  1996cited by this paper
• Separation of E. coli expressing functional cell-wall bound antibody fragments by FACS.

  1996cited by this paper
• Direct random mutagenesis of gene-sized DNA fragments using polymerase chain reaction.

  1995cited by this paper
• Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli.

  1994cited by this paper
• Bacterial aspects associated with the expression of a single-chain antibody fragment in Escherichia coli

  1994cited by this paper
• The complete general secretory pathway in gram-negative bacteria.

  1993cited by this paper
• Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.

  1991cited by this paper
• A single amino acid determinant of the membrane localization of lipoproteins in E. coli.

  1988cited by this paper
• Lipoprotein-28, a cytoplasmic membrane lipoprotein from Escherichia coli. Cloning, DNA sequence, and expression of its gene.

  1986cited by this paper
• Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

  1985cited by this paper
• A prokaryotic membrane anchor sequence: carboxyl terminus of bacteriophage f1 gene III protein retains it in the membrane.

  1982cited by this paper

• The Midas touch: Recombinant antibodies transforming diagnostic platforms.

  2026cites this paper
• Design of fully synthetic signal peptide library and its use for enhanced secretory production of recombinant proteins in Corynebacterium glutamicum

  2024cites this paper
• SARS-CoV-2 vaccine based on ferritin complexes with screened immunogenic sequences from the Fv-antibody library.

  2024cites this paper
• Development of a new genotype–phenotype linked antibody screening system

  2024cites this paper
• Surface display provides an efficient expression system for production of recombinant proteins and bacterial whole cell biosensor in E. coli.

  2024cites this paper
• Advancing Antibody Engineering through Synthetic Evolution and Machine Learning.

  2024cites this paper
• Engineered antibodies targeted to bacterial surface integrate effector functions with toxin neutralization to provide superior efficacy against bacterial infections

  2024cites this paper
• Approaches for High-throughput Quantification of Periplasmic Recombinant Proteins.

  2023cites this paper
• Immunoaffinity biosensors for the detection of SARS-CoV-1 using screened Fv-antibodies from an autodisplayed Fv-antibody library

  2023cites this paper
• Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics Drug Metabolism and Pharmacokinetics

  2022cites this paper
• Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics

  2022cites this paper
• An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages.

  2022cites this paper
• Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy

  2021cites this paper
• Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis.

  2021cites this paper
• Antibody display technologies: selecting the cream of the crop

  2021cites this paper
• Construction of a full-length antibody phage display vector.

  2021cites this paper
• Deep mutational scanning for therapeutic antibody engineering.

  2021cites this paper
• Antibody engineering and its therapeutic applications

  2021cites this paper
• Perspectives on passive antibody therapy and peptide-based vaccines against emerging pathogens like SARS-CoV-2.

  2021cites this paper
• Engineering IgG1 Fc Domains That Activate the Complement System.

  2021cites this paper
• Isolation of full-length IgG antibodies from combinatorial libraries expressed in the cytoplasm of Escherichia coli

  2020cites this paper
• High efficiency CHO cell display-based antibody maturation

  2020cites this paper
• Alternative Methods to Animal Use for Monoclonal Antibody Generation and Production

  2020cites this paper
• Engineered sigma factors increase full-length antibody expression in Escherichia coli.

  2019cites this paper
• Evolving a Peptide: Library Platforms and Diversification Strategies

  2019influential citation
• Illuminating protein interactions in the periplasm

  2019cites this paper
• Engineered Aminoacyl-tRNA Synthetases with Improved Selectivity toward Noncanonical Amino Acids.

  2019cites this paper
• An array of 60,000 antibodies for proteome-scale antibody generation and target discovery

  2019cites this paper
• n Luminescent Assay for nuous Monitoring of Protein ross Biological Membranes aniel

  2019cites this paper
• A High-Resolutio Rapid and Conti Translocation ac

  2019cites this paper
• An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence

  2019cites this paper
• Escherichia coli inner membrane display system for high‐throughput screening of dimeric proteins

  2018cites this paper
• Development and Application of Yeast and Phage Display of Diverse Lanthipeptides

  2018cites this paper
• Affinity maturation of an antibody for the UV-induced DNA lesions 6,4 pyrimidine-pyrimidones

  2018cites this paper
• Superfolder mTurquoise2ox optimized for the bacterial periplasm allows high efficiency in vivo FRET of cell division antibiotic targets

  2018cites this paper
• Production and Characterization of Artificial Spider Silk Fibers with the Same Toughness as Natural Dragline Silk Fibers

  2018cites this paper
• [Single-domain antibody - advances in research and application].

  2018cites this paper
• A High-Resolution Luminescent Assay for Rapid and Continuous Monitoring of Protein Translocation across Biological Membranes

  2018cites this paper
• Going native: Direct high throughput screening of secreted full-length IgG antibodies against cell membrane proteins

  2017cites this paper
• IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions

  2017cites this paper
• Quiescent Body as a Reversible Subcellular Structure Formed in Non-growing Bacterial Cells

  2017cites this paper
• Engineered microbial biosensors based on bacterial two-component systems as synthetic biotechnology platforms in bioremediation and biorefinery

  2017cites this paper
• Human Antibody Discovery Platforms

  2017cites this paper
• Discovery of the Quiescent Body that Functions as a Biological 1 Timer for Growth Resumption of Non-growing Bacterial Cells 2 3

  2017cites this paper
• Engineering CotA Laccase for Acidic pH Stability Using Bacillus subtilis Spore Display.

  2017cites this paper
• 4.14 Rational and Combinatorial Methods to Create Designer Protein Interfaces

  2017cites this paper
• Controlled Hybrid Material Synthesis using Synthetic Biology

  2017cites this paper
• Flow Cytometric Single-Cell Analysis for Quantitative in Vivo Detection of Protein-Protein Interactions via Relative Reporter Protein Expression Measurement.

  2017cites this paper
• Antibody therapies for the prevention and treatment of viral infections

  2017cites this paper
• Protein Engineering: Methods and Applications

  2017cites this paper
• Escherichia coli surface display for the selection of nanobodies

  2017cites this paper
• Utilizing Solid Phase Cloning , Surface Display And Epitope Information for Antibody Generation and Characterization

  2017cites this paper
• Efficient Antibody Assembly in E. coli Periplasm by Disulfide Bond Folding Factor Co-expression and Culture Optimization

  2017cites this paper
• Therapeutic monoclonal antibodies (mAbs) ameliorate disease by two mechanisms that involve the binding and resultant modulation of the function of proteins associated with pathophysiology and the recruitment of effector mechanisms dependent on the crystallizable

  2017cites this paper
• Recombinant scFv antibodies against infectious pancreatic necrosis virus isolated by flow cytometry.

  2016cites this paper
• Immunogenomic engineering of a plug-and-(dis)play hybridoma platform

  2016cites this paper
• Antibody affinity maturation through combining display of two-chain paired antibody and precision flow cytometric sorting

  2016cites this paper
• Screening scFv antibodies against infectious bursal disease virus by co-expression of antigen and antibody in the bacteria display system.

  2016cites this paper
• Engineering antibody therapeutics.

  2016cites this paper
• Discovery of a novel periplasmic protein that forms a complex with a trimeric autotransporter adhesin and peptidoglycan

  2016cites this paper
• Anti-human fibroblast growth factor-21 monoclonal antibody preparation, characterization and analysis of in vitro bioactivity.

  2016cites this paper
• Direct production of functional matrix metalloproteinase—14 without refolding or activation and its application for in vitro inhibition assays

  2016cites this paper
• The History of Therapeutic Monoclonal Antibodies

  2016cites this paper
• Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.

  2016cites this paper
• Screening Techniques Using the Periplasmic Expression of Peptide Libraries and Target Molecules

  2015cites this paper
• Deglycosylation of mAb by EndoS for Improved Molecular Imaging

  2015cites this paper
• Isolation of the neutralization ScFvs Against HBV infection from the Immunized Population.

  2015cites this paper
• A neutralizing scFv antibody against infectious bursal disease virus screened by flow cytometry.

  2015cites this paper
• Bi-specific antibodies with high antigen-binding affinity identified by flow cytometry.

  2015cites this paper
• BrkAutoDisplay: functional display of multiple exogenous proteins on the surface of Escherichia coli by using BrkA autotransporter

  2015cites this paper
• Protein Engineering: Applications to Therapeutic Proteins and Antibodies

  2015cites this paper
• Functional enrichment by direct plasmid recovery after fluorescence activated cell sorting.

  2015cites this paper
• High throughput screening of scFv antibodies against viral hemorrhagic septicaemia virus by flow cytometry.

  2015cites this paper
• Isolation and expression of recombinant viral protein (VP2) from Iranian isolates of Infectious Pancreatic Necrosis Virus (IPNV) in Escherichia coli.

  2014cites this paper
• Epitope mapping of the infectious hematopoietic necrosis virus glycoprotein by flow cytometry

  2014cites this paper
• Anchored periplasmic expression (APEx)-based bacterial display for rapid and high-throughput screening of B cell epitopes

  2014influential citation
• Rapid Isolation of Antibody from a Synthetic Human Antibody Library by Repeated Fluorescence-Activated Cell Sorting (FACS)

  2014cites this paper
• Pushing the Bacterial Envelope

  2014cites this paper
• scFv antibodies against infectious bursal disease virus isolated from a combinatorial antibody library by flow cytometry

  2014cites this paper
• Design and construction of synthetic adhesins driving the specific attachment of Escherichia coli to target surfaces, cells, and tumors

  2014cites this paper
• An engineered autotransporter-based surface expression vector enables efficient display of Affibody molecules on OmpT-negative E. coli as well as protease-mediated secretion in OmpT-positive strains

  2014cites this paper
• Targeting Pili in Enterococcal Pathogenesis

  2014cites this paper
• Structure-based non-canonical amino acid design to covalently crosslink an antibody-antigen complex.

  2014cites this paper
• Generation of "LYmph Node Derived Antibody Libraries" (LYNDAL) : a concept for recovering human monoclonal antibodies with therapeutic potential

  2014cites this paper
• Site-specific immobilization of proteins on non-conventional substrates via solvent-free initiated chemical vapour deposition (iCVD) process

  2014cites this paper
• Methods of genetic diversity creation and functional display for directed evolution experiments

  2014cites this paper
• Using next-generation sequencing for discovery of high-frequency monoclonal antibodies in the variable gene repertoires from immunized mice.

  2014cites this paper
• Development trends for generation of single-chain antibody fragments

  2014cites this paper
• High-level secretory production of recombinant single-chain variable fragment (scFv) in Corynebacterium glutamicum

  2013influential citation
• A neutralization scFv antibody against IL-1β isolated from a NIPA-based bacterial display library.

  2013cites this paper
• A Dual-Mode Surface Display System for the Maturation and Production of Monoclonal Antibodies in Glyco-Engineered Pichia pastoris

  2013cites this paper
• Affinity proteins and their generation

  2013cites this paper
• Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.

  2013cites this paper
• Introducing new effector function to IgG via protein engineering of an IgA-IgG hybrid antibody

  2013cites this paper
• Affinity maturation of antiHER2 monoclonal antibody MIL5 using an epitope-specific synthetic phage library by computational design

  2013cites this paper
• Recombinant production of spider silk proteins.

  2013cites this paper
• Directed evolution: tailoring biocatalysts for industrial applications

  2013cites this paper
• Enhanced production of antibody fragment via SRP pathway engineering in Escherichia coli

  2013influential citation
• Evaluations Of Severe Acute Respiratory Syndrome Coronavirus Therapeutics And A Viral Capacity For Plasticity And Escape.

  2013cites this paper
• Effective phagocytosis of low Her2 tumor cell lines with engineered, aglycosylated IgG displaying high FcγRIIa affinity and selectivity.

  2013cites this paper